Apyx Medical Inc(APYX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

APYX Apyx Medical Inc

Post-Mkt 08-20 19:01:18 EDT

3.03

-0.12

-3.81%

盘后3.03

+0.000.00%

16:10 EDT

High3.29	Low3.03	Vol88.79K
Open3.15	D1 Closing3.15	Amplitude8.25%
Mkt Cap127.59M	Tradable Cap92.40M	Total Shares42.11M
T/O274.35K	T/O Rate0.29%	Tradable Shares30.50M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"APYX","market":"US","secType":"STK","nameCN":"Apyx Medical Inc","latestPrice":3.03,"timestamp":1787256000000,"preClose":3.15,"halted":0,"volume":88790,"hourTrading":{"tag":"盘后","latestPrice":3.03,"preClose":3.03,"latestTime":"16:10 EDT","volume":6604,"amount":20010.12,"timestamp":1787256604850,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03809523809523813,"floatShares":30496100,"shares":42110354,"eps":-0.20302,"marketStatus":"Post-Mkt","change":-0.12,"latestTime":"08-20 19:01:18 EDT","open":3.15,"high":3.29,"low":3.03,"amount":274348,"amplitude":0.08254,"askPrice":3.33,"askSize":48,"bidPrice":2.66,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.20302,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787270400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.15,"preHourTrading":{"tag":"盘前","latestPrice":3.16,"preClose":3.15,"latestTime":"09:24 EDT","volume":10,"amount":31.6,"timestamp":1787232245445,"change":0.01,"changeRate":0.003175,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.03,"preClose":3.03,"latestTime":"16:10 EDT","volume":6604,"amount":20010.12,"timestamp":1787256604850,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.646181,"impliedVol":0.3546,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/APYX","defaultTab":"news","newsList":[{"id":"2657625799","title":"Apyx Medical Holds Annual Shareholder Meeting, Votes on Director Slate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625799","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625799?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:01","pubTimestamp":1786132874,"startTime":"0","endTime":"0","summary":"Apyx Medical holds annual shareholder meeting, votes on director slateApyx Medical held its annual shareholder meeting on Aug. 6, 2026.Shareholders adopted the 2026 Share Incentive Plan, authorizing t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL6M2ldF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657367698","title":"Apyx Medical Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657367698","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657367698?lang=en_us&edition=fundamental","pubTime":"2026-08-07 10:26","pubTimestamp":1786069592,"startTime":"0","endTime":"0","summary":"Apyx Medical Inc reports results for the quarter ended June 30 - Earnings SummaryApyx Medical IncAPYX.OQreported a quarterly adjusted loss of 7 cents per share for the quarter ended June 30, higher th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N44403B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657665898","title":"Apyx Medical Q2 FY26 Net Loss Narrows to $3.2 Million; Revenue Rises 22.1% to $13.9 Million vs Year Ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665898","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657665898?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:04","pubTimestamp":1786050265,"startTime":"0","endTime":"0","summary":"Apyx Medical Q2 FY26 net loss narrows to $3.2 million; revenue rises 22.1% to $13.9 million vs year agoApyx Medical posted Q2 2026 revenue up 22.1% to $13.9 million, led by Surgical Aesthetics up 28.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDLbckBx1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657049668","title":"Apyx Medical Q2 Revenue Beats Estimates on Surgical Aesthetics Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657049668","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657049668?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:40","pubTimestamp":1786048823,"startTime":"0","endTime":"0","summary":"Apyx Medical Q2 revenue beats estimates on surgical aesthetics growthOverviewSurgical aesthetics firm's Q2 revenue rose 22% yr/yr, beating analyst expectationsQ2 adjusted EBITDA loss narrowed and beat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4588","EOLS","BK4198","INMD","LU2324357040.USD","BK4007","APYX","ESTA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657484657","title":"Apyx Medical Corporation Q2 EPS USD -0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2657484657","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657484657?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:06","pubTimestamp":1786046762,"startTime":"0","endTime":"0","summary":"BRIEF-Apyx Medical Corporation Q2 EPS USD -0.07Aug 06  - Apyx Medical Corporation Q2 sales USD 13.884 million vs. IBES estimate USD 13.2 million.Q2 net income USD -3.072 millionQ2 income from operations USD -1.806 millionQ2 pretax profit USD -2.948 millionQ2 adjusted EBITDA USD -705 thousandQ2 gross margin 63.9%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXSZ9NFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661101","title":"Apyx Medical Corporation Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661101","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661101?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046700,"startTime":"0","endTime":"0","summary":"Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece for ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340704/0/en/Apyx-Medical-Corporation-Reports-Second-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562400","title":"Apyx Medical Inc Expected to Post a Loss of 8 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562400","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562400?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:56","pubTimestamp":1785876967,"startTime":"0","endTime":"0","summary":"Apyx Medical Inc <APYX.OQ> expected to post a loss of8cents a share - Earnings PreviewApyx Medical IncAPYX.OQAPYX.Ois expected to  show a rise in quarterly revenue when it reports  results on August 6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44133B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654043360","title":"Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2654043360","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654043360?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:00","pubTimestamp":1785240000,"startTime":"0","endTime":"0","summary":"CLEARWATER, Fla., July  28, 2026  (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the the leader in surgical aesthetics marketed and sold as Renuvion and th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/28/3334184/0/en/Apyx-Medical-Corporation-to-Participate-in-the-Canaccord-Genuity-46th-Annual-Growth-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654503721","title":"Apyx Medical Reshuffles Board Committees, Names Waldman Audit Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2654503721","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654503721?lang=en_us&edition=fundamental","pubTime":"2026-07-25 05:19","pubTimestamp":1784927944,"startTime":"0","endTime":"0","summary":"Apyx Medical reshuffles board committees, names Waldman audit chairApyx Medical reconstituted its board committee lineup on July 24, 2026, reshuffling chairs across audit, governance, regulatory compl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL96qsXn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653472847","title":"Apyx Medical to Report Fiscal Q2 Results, Hosts Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2653472847","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653472847?lang=en_us&edition=fundamental","pubTime":"2026-07-23 20:05","pubTimestamp":1784808340,"startTime":"0","endTime":"0","summary":"Apyx Medical to report fiscal Q2 results, hosts earnings callApyx Medical schedules fiscal Q2 2026 results release for Aug. 6, 2026.Management conference call set for Aug. 6, 2026 at 4:30 p.m. ET, fol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL3Ll8DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4588","BCDF","IE00BN0W2W23.USD","LU2095319765.USD","APYX","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","BK4112","BK4585","LU2210149790.SGD","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653470947","title":"Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2653470947","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653470947?lang=en_us&edition=fundamental","pubTime":"2026-07-23 20:00","pubTimestamp":1784808000,"startTime":"0","endTime":"0","summary":"CLEARWATER, Fla., July  23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion and the A","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/23/3332058/0/en/Apyx-Medical-Corporation-to-Release-Second-Quarter-of-Fiscal-Year-2026-Financial-Results-on-August-6-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651562116","title":"HC Wainwright Initiates Apyx Medical at Buy With $7 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2651562116","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651562116?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:23","pubTimestamp":1783941800,"startTime":"0","endTime":"0","summary":"Apyx Medical (APYX) has an average rating of buy and mean price target of $6.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651711351","title":"Apyx Medical Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2651711351","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651711351?lang=en_us&edition=fundamental","pubTime":"2026-07-13 18:23","pubTimestamp":1783938180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APYX/analyst-ratings(END) Dow Jones NewswiresJuly 13, 2026 06:23 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646511360","title":"Apyx Medical Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2646511360","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646511360?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:15","pubTimestamp":1782504900,"startTime":"0","endTime":"0","summary":"Apyx Medical announces annual shareholder meetingApyx Medical will hold its annual shareholder meeting in Uniondale, New York on Aug. 6, 2026.Shareholders will vote on the election of five directors, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL2YKpxD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644729416","title":"Apyx Medical - Appoints Stavros Vizirgianakis as Executive Chairman Effective June 11, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2644729416","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644729416?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:09","pubTimestamp":1781726974,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42P0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644291057","title":"Apyx Medical names Stavros Vizirgianakis executive chairman of board","url":"https://stock-news.laohu8.com/highlight/detail?id=2644291057","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644291057?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:06","pubTimestamp":1781726786,"startTime":"0","endTime":"0","summary":"Apyx Medical named board chairman Stavros Vizirgianakis as executive chairman under a letter agreement dated June 11, 2026.Vizirgianakis will provide strategic leadership, governance oversight, investor engagement support, capital markets advice, corporate development guidance.Role is positioned outside the officer structure, with duties focused on board-level leadership and support for management execution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apyx Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL4v32CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333781","title":"Apyx Medical study shows 81.8% cellulite improvement using Avéli-Renuvion combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333781?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:03","pubTimestamp":1779365012,"startTime":"0","endTime":"0","summary":"Apyx Medical reported published clinical data on May 21, 2026 in Aesthetic Surgery Journal Open Forum from a prospective, investigator-initiated study evaluating a combined use of Avéli subcision followed by the company’s Renuvion device for cellulite and skin laxity.The results have already been presented in the publication, covering outcomes through 180 days in 22 patients treated in a single session.The study showed visible, sustained improvement in cellulite appearance over time, with imaging indicating meaningful reductions in dimpling in some cases.Findings also supported improved skin quality consistent with ongoing tissue remodeling, based on laboratory analysis in a subset of patients.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDLlWT75:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU0314104364.USD","BK4082","SG9999014005.SGD","LU2210149790.SGD","NDAQ","BK4588","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","APYX","BK4585","BK4112","IE00BKPKM429.USD","SG9999014021.USD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635712055","title":"Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction","url":"https://stock-news.laohu8.com/highlight/detail?id=2635712055","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635712055?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:00","pubTimestamp":1778760000,"startTime":"0","endTime":"0","summary":"Analysis showed that liposuction followed by helium plasma RF was associated with higher patient-reported satisfaction with abdominal appearance, lower abdominoplasty and revision rates, and comparabl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294885/0/en/Apyx-Medical-Corporation-Announces-Retrospective-Clinical-Publication-Evaluating-Clinical-Benefit-of-Renuvion-Used-in-Combination-with-Liposuction.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634016238","title":"Apyx Medical Shares Rise After FDA Expands Clearance for AYON Liposuction Feature","url":"https://stock-news.laohu8.com/highlight/detail?id=2634016238","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634016238?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:21","pubTimestamp":1778512860,"startTime":"0","endTime":"0","summary":"Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction.Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days.The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient.Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634812262","title":"BRIEF-Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring System™","url":"https://stock-news.laohu8.com/highlight/detail?id=2634812262","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634812262?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:52","pubTimestamp":1778503928,"startTime":"0","endTime":"0","summary":"BRIEF-Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring SystemMay 11 (Reuters) - Apyx Medical Inc APYX.O:APYX MEDICAL CORPORAT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA2Q3T2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apyxmedical.com","stockEarnings":[{"period":"1week","weight":0.0535},{"period":"1month","weight":-0.226},{"period":"3month","weight":-0.2588},{"period":"6month","weight":-0.1667},{"period":"1year","weight":0.599},{"period":"ytd","weight":-0.1}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company's Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also offers hand pieces for open and laparoscopic procedures, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.052775},{"month":2,"riseRate":0.4375,"avgChangeRate":0.02708},{"month":3,"riseRate":0.25,"avgChangeRate":-0.087392},{"month":4,"riseRate":0.65625,"avgChangeRate":0.033988},{"month":5,"riseRate":0.515152,"avgChangeRate":0.071476},{"month":6,"riseRate":0.484848,"avgChangeRate":0.038229},{"month":7,"riseRate":0.606061,"avgChangeRate":0.026692},{"month":8,"riseRate":0.484848,"avgChangeRate":0.020338},{"month":9,"riseRate":0.4375,"avgChangeRate":0.020348},{"month":10,"riseRate":0.4375,"avgChangeRate":0.012238},{"month":11,"riseRate":0.46875,"avgChangeRate":0.044253},{"month":12,"riseRate":0.387097,"avgChangeRate":-0.006745}],"exchange":"NASDAQ","name":"Apyx Medical Inc","nameEN":"Apyx Medical Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apyx Medical Inc(APYX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Apyx Medical Inc(APYX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Apyx Medical Inc,APYX,Apyx Medical Inc股票,Apyx Medical Inc股票老虎,Apyx Medical Inc股票老虎国际,Apyx Medical Inc行情,Apyx Medical Inc股票行情,Apyx Medical Inc股价,Apyx Medical Inc股市,Apyx Medical Inc股票价格,Apyx Medical Inc股票交易,Apyx Medical Inc股票购买,Apyx Medical Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apyx Medical Inc(APYX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Apyx Medical Inc(APYX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction